Medica SpA
MIL:MDC
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IT |
M
|
Medica SpA
MIL:MDC
|
125.9m EUR |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8.7T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
31.5B CHF |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
37.3B USD |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
122.5B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.1B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.8B GBP |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
44B CNY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.6B CHF |
Loading...
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.5T KRW |
Loading...
|
Market Distribution
| Min | -24 712% |
| 30th Percentile | 1.6% |
| Median | 5.3% |
| 70th Percentile | 10.1% |
| Max | 3 667.8% |
Other Profitability Ratios
Medica SpA
Glance View
Medica SpA engages in the design, development, production, and sale of medical devices and electro-medical machines for blood filtration as well as water treatment. The company is headquartered in Medolla, Modena. The company went IPO on 2021-11-03. Through subsidiaries, such as Tecnoideal sel the Company not only offers dialyzers, ultrafilters, HDF online sets, bloodlines, and pediatric dialyzers for dialysis treatment but also provides critical care CRRT equipment, hemofilter, pediatric filters, C02 removal, apheresis equipment, fractionator-cascade filtration, plasma filters, and leukocyte adsorber. The company also supplies Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentration. The company is engaged in water purification offering systems, including lab-pharma-industrial filtrations, individual water purifiers, and point-of-use filtrations. The firm provides infusion sets, urodynamic systems, palm bladder scanner and gastroenterology systems, among others. The company operates globally.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Medica SpA is 5.1%, which is below its 3-year median of 6.8%.
Over the last 2 years, Medica SpA’s Net Margin has decreased from 11.4% to 5.1%. During this period, it reached a low of 5.1% on Jul 30, 2023 and a high of 11.4% on Dec 1, 2021.